Enter the Danish market with the right evidence, language and accountable owners.
ClinicOps is Danish-led and supports international manufacturers, authorised representatives, research teams and localisation partners that need a controlled path into Denmark while staying aligned with the wider EU framework.
What this service actually does
Authority & requirement map
Identify the Danish and EU authorities, public primary sources, registrations, language surfaces and review owners relevant to the declared product or workflow.
Controlled Danish localisation
Map approved English/source content to Danish derivative content, preserve terminology and version provenance, route questions to the qualified owner and document closure.
Evidence reconciliation
Compare declared controlled sources with EUDAMED, regulatory master data, IFU/labelling, SS(C)P, study or operational records placed in scope.
Partner handoff
Package unresolved legal, regulatory, clinical, safety or specialist questions for the appropriate client owner or an independent subject-matter expert whose credentials are checked for that engagement, rather than guessing.
Denmark first, Europe connected
The Danish Medicines Agency administers medical-device legislation in Denmark and works within the EU MDR/IVDR framework. For medicinal clinical trials in Denmark, the Danish Medicines Agency and ethics committees collaborate through the CTR/CTIS pathway. Where work touches healthcare delivery, authorisation or treatment-place governance, the Danish Patient Safety Authority becomes relevant. The exact authority set is scoped to the engagement rather than assumed.
Primary Danish authorities used in scope
- Danish Medicines Agency — medical devices legislation and guidance
Primary Danish authority source for medical-device legislation, market surveillance and national implementation context.
- Danish Medicines Agency — clinical trials
Primary Danish source for medicinal clinical-trial applications and national CTR/CTIS processes.
- Danish Patient Safety Authority — treatment-place supervision
Relevant where the workflow enters healthcare-delivery governance, authorised health-professional activity or patient-safety supervision.
- National Center for Ethics / Danish research-ethics committees
Relevant to ethical review of research, medicinal trials and clinical investigations where applicable.
- Danish Data Protection Agency
Primary Danish source for data-protection requirements where personal data or health data enters scope.
Connected EU layer
MDR / IVDR & EUDAMED
EU medical-device rules, MDCG guidance and EUDAMED lifecycle data.
CTR / CTIS & GCP
European trial authorisation and ICH GCP evidence context where a Danish-market question touches trial documents.
AI / EHDS / digital health
EU AI governance and health-data frameworks where they apply to the declared clinical workflow.
Language is controlled evidence, not a side service
ClinicOps treats translation and localisation as part of change control: approved source, target-language version, terminology decisions, reviewer identity, unresolved questions, approval and version closure. The service can coordinate English↔Danish work and specialist review without presenting translation alone as regulatory approval.
The same discipline covers pharmacovigilance. Global PV systems hit three Danish walls: local medical literature that must be screened in Danish under GVP Module VI, Danish-language case reports and narratives that need medically literate translation inside statutory reporting timelines, and safety communications (DHPCs) that must read correctly to Danish clinicians before release. ClinicOps provides that capacity as controlled evidence work — source, target, terminology decision, reviewer, closure — while qualified PV sign-off remains with the client’s safety organisation. No QPPV, deputy or national contact-person role is taken.
Qualified Danish pharmacovigilance capability
Danish pharmacovigilance work is led by Ali Iskandar — MSc in Medicine (Translational Medicine), Aalborg University — with hands-on PV experience and native Danish language capability.
Education & language
MSc in Medicine (Translational Medicine), Aalborg University · ICH-GCP trained · Native Danish, professional English. GVP-framework familiarity from operational pharmacovigilance practice.
Hands-on PV experience
ICSR case processing, MedDRA coding and safety-database work (Argus, ArisG, EVWEB/EVDAS) in a specialist PV provider setting — plus medically informed English↔Danish case-narrative translation and Danish review of DHPCs and safety communications before release.
Relevant work
Danish medical-literature screening under GVP Module VI · local-literature workflows · safety-document review · ICSR and case-narrative language work · DHPC and safety-communication review · PV documentation and terminology/version control · controlled safety-information workflows.
Buyer and boundary
Buyer: MAHs, PV service providers and CROs covering Denmark from a global hub. Boundary: formal QPPV, deputy and national contact-person responsibilities are assumed only where explicitly appointed, and medical assessment stays with your safety organisation's qualified reviewers.